BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 1747436)

  • 1. Positron emission tomography and magnetic resonance imaging: a review and a local circuit neurons hypo(dys)function hypothesis of schizophrenia.
    Bachneff SA
    Biol Psychiatry; 1991 Nov; 30(9):857-86. PubMed ID: 1747436
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural and functional brain imaging in schizophrenia.
    Cleghorn JM; Zipursky RB; List SJ
    J Psychiatry Neurosci; 1991 Jul; 16(2):53-74. PubMed ID: 1911736
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Neuroimaging in schizophrenia].
    Lanzenberger R; Kasper S
    Fortschr Neurol Psychiatr; 2005 Nov; 73 Suppl 1():S51-9. PubMed ID: 16270245
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemical and physiologic brain imaging in schizophrenia.
    McClure RJ; Keshavan MS; Pettegrew JW
    Psychiatr Clin North Am; 1998 Mar; 21(1):93-122. PubMed ID: 9551493
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Searching for the neuropathology of schizophrenia: neuroimaging strategies and findings.
    Lieberman JA
    Am J Psychiatry; 1999 Aug; 156(8):1133-6. PubMed ID: 10450250
    [No Abstract]   [Full Text] [Related]  

  • 6. [Background and findings of neuroimaging in schizophrenia: an update].
    Cuevas-Esteban J; Campayo A; Gutiérrez-Galve L; Gracia-García P; López-Antón R
    Rev Neurol; 2011 Jan; 52(1):27-36. PubMed ID: 21246491
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Structural and functional cerebral changes in patients with schizophrenia].
    Rubin PJ; Hemmingsen RP
    Ugeskr Laeger; 1993 Jan; 155(1):16-21. PubMed ID: 8421841
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuroimaging in schizophrenia research.
    Gur RE; Pearlson GD
    Schizophr Bull; 1993; 19(2):337-53. PubMed ID: 8322037
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Psychopathology of schizophrenia and brain imaging].
    Gross G; Huber G
    Fortschr Neurol Psychiatr; 2008 May; 76 Suppl 1():S49-56. PubMed ID: 18461545
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Abnormalities in midline attentional circuitry in schizophrenia: evidence from magnetic resonance and positron emission tomography.
    Andreasen NC; Swayze V; O'Leary DS; Nopoulos P; Cizadlo T; Harris G; Arndt S; Flaum M
    Eur Neuropsychopharmacol; 1995; 5 Suppl():37-41. PubMed ID: 8775757
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Specific relationship between prefrontal neuronal N-acetylaspartate and activation of the working memory cortical network in schizophrenia.
    Bertolino A; Esposito G; Callicott JH; Mattay VS; Van Horn JD; Frank JA; Berman KF; Weinberger DR
    Am J Psychiatry; 2000 Jan; 157(1):26-33. PubMed ID: 10618009
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neural mechanisms of anhedonia in schizophrenia: a PET study of response to unpleasant and pleasant odors.
    Crespo-Facorro B; Paradiso S; Andreasen NC; O'Leary DS; Watkins GL; Ponto LL; Hichwa RD
    JAMA; 2001 Jul; 286(4):427-35. PubMed ID: 11466121
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuroanatomy and neurophysiology in schizophrenia.
    Kasai K; Iwanami A; Yamasue H; Kuroki N; Nakagome K; Fukuda M
    Neurosci Res; 2002 Jun; 43(2):93-110. PubMed ID: 12067745
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Brain serotonin 5-HT(1A) receptor binding in schizophrenia measured by positron emission tomography and [11C]WAY-100635.
    Tauscher J; Kapur S; Verhoeff NP; Hussey DF; Daskalakis ZJ; Tauscher-Wisniewski S; Wilson AA; Houle S; Kasper S; Zipursky RB
    Arch Gen Psychiatry; 2002 Jun; 59(6):514-20. PubMed ID: 12044193
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MRI-SPECT and PET-EEG findings on brain dysfunction in schizophrenia.
    Günther W
    Prog Neuropsychopharmacol Biol Psychiatry; 1992 Jul; 16(4):445-62. PubMed ID: 1641491
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Positron emission tomography in schizophrenia: a new perspective.
    Patel NH; Vyas NS; Puri BK; Nijran KS; Al-Nahhas A
    J Nucl Med; 2010 Apr; 51(4):511-20. PubMed ID: 20237027
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The reduced neuropil hypothesis: a circuit based model of schizophrenia.
    Selemon LD; Goldman-Rakic PS
    Biol Psychiatry; 1999 Jan; 45(1):17-25. PubMed ID: 9894571
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cortico-thalamic hypo- and hyperconnectivity extend consistently to basal ganglia in schizophrenia.
    Avram M; Brandl F; Bäuml J; Sorg C
    Neuropsychopharmacology; 2018 Oct; 43(11):2239-2248. PubMed ID: 29899404
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The impact of NMDA receptor hypofunction on GABAergic neurons in the pathophysiology of schizophrenia.
    Cohen SM; Tsien RW; Goff DC; Halassa MM
    Schizophr Res; 2015 Sep; 167(1-3):98-107. PubMed ID: 25583246
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Imaging studies - differential action of typical and atypical antipsychotics in a network perspective.
    Vernaleken I; Cumming P; Gründer G
    Pharmacopsychiatry; 2008 Sep; 41 Suppl 1():S60-9. PubMed ID: 18756422
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.